Namita Kumari
About Namita Kumari
Data last updated:
Namita Kumari is a Director at Drug Point Private Limited (since 2020), Director at My Drugpoint Private Limited (since 2022) and Director at Gen X Infracon Private Limited (since 2024). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹16.96 Cr; the largest is Drug Point Private Limited at ₹10.64 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Drug Point Private Limited U24230BR2020PTC045902 | Director | 20 Apr 2020 | 2020 | ₹10.64 Cr (FY 2023) | Active |
 My Drugpoint Private Limited U52310BR2022PTC056616 | Director | 24 Feb 2022 | 2022 | ₹6.31 Cr (FY 2025) | Active |
| Gen X Infracon Private Limited U42909BR2024PTC067204 | Director | 18 Jan 2024 | 2024 | Active |
Board colleagues of Namita Kumari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anupam Kumar | 03030975 | Drug Point Private Limited , My Drugpoint Private Limited | Director |
| Rakesh Ranjan | 03030982 | Drug Point Private Limited , Gen X Infracon Private Limited | Additional Director |
| Srishti Nayyar | 08735699 | Drug Point Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Namita Kumari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Namita Kumari
Namita Kumari currently holds 3 directorships: Drug Point Private Limited (Director, since 20 Apr 2020, revenue ₹10.64 Cr (FY 2023)); My Drugpoint Private Limited (Director, since 24 Feb 2022, revenue ₹6.31 Cr (FY 2025)); Gen X Infracon Private Limited (Director, since 18 Jan 2024).
Namita Kumari was first appointed on 20 Apr 2020 as Director at Drug Point Private Limited. The most recent appointment on record is 18 Jan 2024 at Gen X Infracon Private Limited.
The 2 current companies of Namita Kumari that report revenue have a combined latest revenue of ₹16.96 Cr: Drug Point Private Limited ₹10.64 Cr (FY 2023); My Drugpoint Private Limited ₹6.31 Cr (FY 2025).
The current boards of Namita Kumari's companies include Anupam Kumar (Drug Point Private Limited), Rakesh Ranjan (Drug Point Private Limited), Srishti Nayyar (Drug Point Private Limited).